We’ve seen vigorous debates here on Retraction Watch about when studies should be retracted. Does it require fraud? Just not being reproducible? Somewhere in between?
Given the apparent divergence of opinions on the issue, we thought it would be worth highlighting a case that involves language we haven’t seen before. Here’s the notice for “Apoptosis of CT26 colorectal cancer cells induced by Clostridium difficile toxin A stimulates potent anti-tumor immunity,” which originally appeared online in Biochemical and Biophysical Research Communications in April: Continue reading Two retractions in biophysics journal, one because article is “too preliminary and potentially misleading”